Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novartis AG (GB:0QLR)
LSE:0QLR
Novartis AG (0QLR) Share Forecast & Price Target
9 Followers
See the Price Targets and Ratings of:
0QLR Analyst Ratings
Moderate Buy
9 Buy
5 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0QLR Stock 12 Month Forecast
Average Price Target
CHF103.36
▲(5.41% Upside)
| Highest Price TargetCHF118.00 | Average Price TargetCHF103.36 | Lowest Price TargetCHF85.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Berenberg Bank
Reiterated
07/22/24
Bernstein
Reiterated
07/22/24
Deutsche Bank
Downgraded
07/19/24
DZ BANK AG
Reiterated
07/19/24
J.P. Morgan
Reiterated
07/19/24
Barclays
Reiterated
07/19/24
Jefferies
Reiterated
07/18/24
Bank of America Securities
Reiterated
07/18/24
Kepler Capital
Reiterated
07/18/24
Goldman Sachs
CHF106
Buy
CHF106.00
(8.10% Upside)
Reiterated
07/18/24
Goldman Sachs Keeps Their Buy Rating on Novartis AG (NOVN)
Morgan Stanley
CHF100→CHF103
Hold
CHF103.00
(5.04% Upside)
Reiterated
07/12/24
Novartis (NOVN:SW) (NVS) PT Raised to CHF103 at Morgan StanleyMorgan Stanley analyst Mark Purcell raised the price target on Novartis (NOVN:SW) (NYSE: NVS) to CHF103.00 (from CHF100.00) while maintaining a Equalweight rating.
Oddo BHF
CHF95→CHF112
Buy
CHF112.00
(14.22% Upside)
Upgraded
07/11/24
Novartis upgraded to Outperform from Neutral at Oddo BHFNovartis upgraded to Outperform from Neutral at Oddo BHF
Citi
CHF97
Hold
CHF97.00
(-1.08% Downside)
Reiterated
07/05/24
Novartis AG (NOVN) Gets a Hold from Citi
Stifel Nicolaus
CHF100→CHF103
Buy
CHF103.00
(5.04% Upside)
Reiterated
07/01/24
Buy Rating for Novartis AG on Strong Sales and Robust Operating Performance
Best Analysts Covering Novartis AG
Which Analyst Should I Follow If I Want to Buy GB:0QLR and Sell After:
1 Month
xxx
Success Rate
23/41 ratings generated profit
Average Return
+0.94%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 56.10% of your transactions generating a profit, with an average return of +0.94% per trade.
3 Months
xxx
Success Rate
9/13 ratings generated profit
Average Return
+3.52%
reiterated a xxx
rating 30 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +3.52% per trade.
1 Year
Success Rate
15/16 ratings generated profit
Average Return
+14.32%
reiterated a buy rating 13 days ago
Copying David Evans's trades and holding each position for 1 Year would result in 93.75% of your transactions generating a profit, with an average return of +14.32% per trade.
2 Years
xxx
Success Rate
13/13 ratings generated profit
Average Return
+18.99%
reiterated a xxx
rating 30 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +18.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0QLR Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
0
0
0
0
0
Buy
22
25
25
22
26
Hold
8
6
5
6
10
Sell
3
4
2
2
3
Strong Sell
0
0
0
0
0
total
33
35
32
30
39
Each month's total comprises the sum of three months' worth of ratings.
0QLR Financial Forecast
0QLR Stock Forecast FAQ
What is GB:0QLR’s average 12-month price target, according to analysts?
Based on analyst ratings, Novartis AG’s 12-month average price target is CHF103.36.
What is GB:0QLR’s upside potential, based on the analysts’ average price target?
Novartis AG has 5.41% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Novartis AG a Buy, Sell or Hold?
Novartis AG has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 5 hold ratings and 1 sell ratings.
What is Novartis AG’s share price target?
The average share price target for Novartis AG is CHF103.36. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF118.00 ,and the lowest forecast is CHF85.00. The average share price target represents 5.41% Increase from the current price of CHF98.058.
The highest analyst share price target is CHF118.00 ,and the lowest forecast is CHF85.00. The average share price target represents 5.41% Increase from the current price of CHF98.058.
What do analysts say about Novartis AG?
Novartis AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of Novartis AG?
To buy shares of GB:0QLR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.